Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about IIHMR announces to launch ‘S D Gupta School of Public Health’ on its 36th Foundation Day
- Read more about Penn Medicine researchers discover a rare genetic form of dementia
Caption: Abnormal neurofibrillary tangles (NFTs) -- a buildup of tau protein in parts of the brain -- helped Edward Lee, MD, PhD, an assistant professor of Pathology and Laboratory Medicine, and other Penn Medicine scientists uncover this new form of dementia.
1 October 2020

Fake Pharmacy mark sheet racket busted with help of Gujarat State Pharmacy Council

Four people, who involved in selling of fake pharmacy license and mark sheet, are arrested by crime branch with help of Gujarat State Pharmacy Council (GSPC). They were hacked in GSPC website and creating fake records of people and making them registered under pharmacy council using online tricks.
- Read more about New study says physical distancing is more effective than travel bans
- Read more about Covid-19 crisis inspires a “Research Culture” in Ayush disciplines
The Covid-19 pandemic has brought the spotlight on the health-promotive and disease-preventive solutions of Ayush disciplines. What has not come into the limelight is the emerging nation-wide trend in the Ayush disciplines, of taking up evidence-based studies.
- Read more about U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA). Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight. This approval makes XELJANZ the first and only Janus kinase (JAK) inhibitor approved in the U.S. for the treatment of pcJIA.
- Read more about Bharat Biotech Inks Licensing Deal with Washington University School of Medicine in St. Louis to advance COVID-19 Intranasal Vaccine Technology
Vaccine Innovator, Bharat Biotech announces today, a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp- adenovirus, single dose intranasal vaccine for COVID-19. Bharat Biotech owns the rights to distribute the vaccine in all markets except USA, Japan and Europe.
- Read more about Aequs collaborates with the University of Illinois to develop AQovent™
Aequs, India's leading aerospace precision engineering and manufacturing company, announced the launch of AQovent™, a medical-grade, low-cost, and mass-produced mechanical resuscitator. AQovent™ is an oxygen-driven emergency resuscitator that can provide constant-flow, pressure-cycled ventilation automatically to patients in respiratory distress. Aequs is manufacturing these resuscitators in India based on the license procured on the concept design from the University of Illinois, U.S.A.
- Read more about SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics
Sun Pharma Advanced Research Company Ltd announced the grant of an exclusive license to Tripoint Therapeutics LLC, USA (Tripoint) to commercialize ElepsiaTM XR 1000 mg and ElepsiaTM XR 1500 mg tablets in the USA.
- Read more about Strides receives USFDA approval for Butalbital, Acetaminophen, and Caffeine Tablets
Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Butalbital, Acetaminophen, and Caffeine Tablets USP, 50 mg/325 mg/40 mg from the United States Food & Drug Administration (USFDA).